Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Rosella, Silvestrini"'
Autor:
Sara Bravaccini, Giuseppe Bronte, Emanuela Scarpi, Sara Ravaioli, Roberta Maltoni, Anita Mangia, Maria Maddalena Tumedei, Maurizio Puccetti, Patrizia Serra, Lorenzo Gianni, Laura Amaducci, Nicoletta Biglia, Valentina Bounous, Angelo Virgilio Paradiso, Rosella Silvestrini, Dino Amadori, Andrea Rocca
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: In the Italian Breast Cancer Intergroup Studies (IBIS) 3 phase III trial, we compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF) alone to sequential epirubicin/CMF regimens in patients with rapidly proliferating early breast can
Externí odkaz:
https://doaj.org/article/9c335358d56743fda946544b114d2f88
Autor:
Sara Bravaccini, Andrea Amadori, Emanuela Scarpi, Maria Maddalena Tumedei, Wainer Zoli, Rosella Silvestrini
Publikováno v:
Analytical Cellular Pathology, Vol 35, Iss 5-6, Pp 377-380 (2012)
Telomerase, a fundamental marker of neoplastic transformation, is widely expressed in both premalignant intraepithelial lesions and in most malignant lesions of the uterine cervix. We determined telomerase activity (TA) in uterine cervix by Repeat Am
Externí odkaz:
https://doaj.org/article/8f84263057d04f24a546e19f90184e22
Publikováno v:
Indian Journal of Urology, Vol 25, Iss 1, Pp 40-46 (2009)
Bladder cancer has an incidence of 15 cases per 100,000 persons in the global population and is the most common tumor of the urinary tract. Imaging techniques, cytoscopy, and cytology are either invasive or not sufficiently accurate to detect early s
Externí odkaz:
https://doaj.org/article/d4bf81ff10964c66abed1c4ae116094c
Autor:
Daniele Calistri, Claudia Rengucci, Chiara Molinari, Enrico Ricci, Elena Cavargini, Emanuela Scarpi, Gian Luigi Milandri, Carla Fabbri, Alberto Ravaioli, Antonio Russo, Dino Amadori, Rosella Silvestrini
Publikováno v:
Cellular Oncology, Vol 31, Iss 1, Pp 11-17 (2009)
Background: A variety of molecular markers have been evaluated for the development of a non-invasive approach to the diagnosis of colorectal cancer. We aimed to validate the diagnostic accuracy, using the same threshold as in the previous pilot study
Externí odkaz:
https://doaj.org/article/2a7ad0baf324484697d3986b5b98a6a0
Autor:
Paola Ulivi, Laura Mercatali, Gian-Luca Casoni, Emanuela Scarpi, Lauro Bucchi, Rosella Silvestrini, Stefano Sanna, Marco Monteverde, Dino Amadori, Venerino Poletti, Wainer Zoli
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e57401 (2013)
BACKGROUND: Non-invasive early detection of lung cancer could reduce the number of patients diagnosed with advanced disease, which is associated with a poor prognosis. We analyzed the diagnostic accuracy of a panel of peripheral blood markers in dete
Externí odkaz:
https://doaj.org/article/f0f6033cfb0e44a9ba7c884b942a47ad
Autor:
Angelo Paradiso, Giuseppe Bronte, Patrizia Serra, Valentina Elisabetta Bounous, Anita Mangia, Sara Ravaioli, Andrea Rocca, Lorenzo Gianni, Dino Amadori, Maria Maddalena Tumedei, Sara Bravaccini, Laura Amaducci, Maurizio Puccetti, Rosella Silvestrini, Roberta Maltoni, Emanuela Scarpi, Nicoletta Biglia
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background:In the Italian Breast Cancer Intergroup Studies (IBIS) 3 phase III trial, we compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF) alone to sequential epirubicin/CMF regimens in patients with rapidly proliferating early breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a585769903ffdde7da077171dc0ac36b
http://hdl.handle.net/2318/1735113
http://hdl.handle.net/2318/1735113
Autor:
Chiara Arienti, Valentina Casadio, Marzia Di Donato, Ugo De Giorgi, Gabriella Castoria, Mirella Falconi, Sara Pignatta, Wainer Zoli, Elisa Gabucci, Anna Tesei, Rosella Silvestrini
Publikováno v:
Molecular and Cellular Endocrinology. 382:314-324
Advanced prostate cancers, initially sensitive to androgen deprivation therapy, frequently progress to the castration-resistant prostate cancer phenotype (CRPC) through mechanisms not yet fully understood. In this study we investigated mitochondrial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e57e9cf0a6f2090853af066150cd9900
https://doi.org/10.1016/j.mce.2013.10.022
https://doi.org/10.1016/j.mce.2013.10.022
Autor:
Sara, Bravaccini, Giuseppe, Bronte, Emanuela, Scarpi, Sara, Ravaioli, Roberta, Maltoni, Anita, Mangia, Maria Maddalena, Tumedei, Maurizio, Puccetti, Patrizia, Serra, Lorenzo, Gianni, Laura, Amaducci, Nicoletta, Biglia, Valentina, Bounous, Angelo Virgilio, Paradiso, Rosella, Silvestrini, Dino, Amadori, Andrea, Rocca
Publikováno v:
Therapeutic Advances in Medical Oncology
Background: In the Italian Breast Cancer Intergroup Studies (IBIS) 3 phase III trial, we compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF) alone to sequential epirubicin/CMF regimens in patients with rapidly proliferating early breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c9f72f7e7e1f76280d45eb22701dbd5b
https://pubmed.ncbi.nlm.nih.gov/32158505
https://pubmed.ncbi.nlm.nih.gov/32158505
Autor:
Rosella Silvestrini
Publikováno v:
Cellular Oncology, Vol 27, Iss 5-6, Pp 355-355 (2005)
Externí odkaz:
https://doaj.org/article/8deea0161f0842209beffa6873c294bd
Autor:
Rosella Silvestrini, Sara Bravaccini, Maurizio Puccetti, Sara Ravaioli, Maria Maddalena Tumedei, Lucia Bedei
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 27(4)
Ductal carcinoma in situ (DCIS) is a highly heterogenous tumor that is now more frequently diagnosed because of the increased number of screening programs. Women with DCIS are mainly treated with conservative surgery almost always followed by radioth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca8586f269f526a2a83bca8456e2b1b
https://pubmed.ncbi.nlm.nih.gov/28968271
https://pubmed.ncbi.nlm.nih.gov/28968271